Illumina – Independent Director, Ethics Advisory Board
Cardiff Oncology – Independent Director (2)
Pliant Therapeutics – Independent Director (2)
Fate Therapeutics – Independent Director
Histogen – Independent Director (2)
Mammogen – Independent Director
SioGene Therapies -Independent Director
Vaxxinity – Independent Director
Alexion – Chief Medical Officer
Alovant – President and Chief Operating Officer
Ascensia – Chief Medical Officer
Aviwell – Chief Executive Officer & Director
Bexion Pharmaceuticals – Chief Executive Officer & Director, Chief Financial Officer
BioLA – Chief Executive Officer
Brickell Biotech – Chief Medical Officer
Cardiff Oncology – Chief Scientific Officer
Cellectis – Chief Medical Officer
Cellics – Chief Executive Officer & Director
Confidential – Chief Financial Officer
Critical Path Institute – Chief Executive Officer & Director
Dermavant Sciences – Chief Scientific Officer
Engrail – CSO and SVP of Development
Exciva – Chief Executive Officer & Director
Fate Therapeutics – Chief Medical Officer
Gallant – Chief Executive Officer & Director
Glenmark – Chief Commercial Officer
Imagion – Chief Development Officer
Inivata, Inc. – Chief Medical Officer
Lineage Cell Therapeutics – Chief Executive Officer & Director
Mammogen – Chief Executive Officer & Director
Neuraptive – Chief Operating Officer and EVP, Head of R&D
New Rhein – Managing Partner & Chief Medical Officer
Onchilles – Chief Scientific Officer
Pierian – Chief Executive Officer & Director
Poseida – President, Gene Therapy
Sanofi – Chief Patient Officer
United Bomedical – EVP, Research & Development
United Neuroscience – Chief Scientific Officer
Valavant – Chief Executive Officer & Director
3T Biosciences – Head of Finance
Accent Therapeutics – Head of Biology
Adaptimmune -VP, Clinical Development
Advaxis – VP, Medical
Alexion – SVP, Medical Affairs, Country Leader, VP, Clinical Development Neurology, VP, Quality Operations
Almatica – VP, Regulatory Affairs
Amicus – SVP, Clinical Research, Gene Therapy, Global Head of Medical Affairs
Ascensia – Global Head, Clinical Development & Operations
Atyr – VP, Regulatory Affairs
Bayer Healthcare – Therapeutic Head, Cardiovascular, Head of Development Center, Skincare, Country Head France, BAH, Pricing Market Access EU
Embecta (subsidiary of BD) – Global Head Medical, Clinical and Scientific Affairs & Chief Medical Officer
Becton Dickinson – VP, Medical Affairs (4)
Beigene – SVP, Global Head Business Development, VP, Alliance Project, VP, Global Clinical Operations, VP, Head of Europe Medical Affairs, VP, Head of Late Stage Development
Blueprint Medicines – VP, Biology, VP, Translational Medicine
Cardiff Oncology Inc. – SVP, Regulatory Affairs
Cellectis – SVP, Regulatory Affairs
Clovis – VP, Safety & Pharmacovigilance
Fate Therapeutics – SVP, Corporate Development, SVP, Technical Operations, VP, Clinical Development (3), VP, Solid Tumor Biology
Glenmark – VP, Market Access
Humacyte Inc. – VP, Scientific & Medical Communications
Idorsia – Clinical Lead – Neurology
Insmed – SVP, Head of Clinical Development
Intellectual Ventures – Commercial Lead, Medical Technologies
Intercept- VP, Regulatory Affairs, R&D
Jasper Therapeutics – VP, Clinical Operations
Johnson & Johnson – VP, Biologics Discovery, Head, J&J Innovation West NA, Australia & New Zealand
LabCentral – Executive Director, Ignite
Myovant – SVP, Pharma. Operations and Development
Nutrinia – VP, Regulatory Affairs
Pfizer – VP, Development Head, Immuno-Oncology Medicine Team Lead
Pharma Essentia – Global Head of Pharmacovigilance
Regeneron – Global Program Head – Oncology, VP, Strategic Program Direction TA Head, Oncology, VP, Global Program Head Immunology, Strategic Program Director, CV/META, Strategic Program Heads (2)
Regulus – VP, Preclinical Development
Sanofi – Head of Bioprocesses
Talis BioMedical – VP, Assay Development
Urovant – VP, Manufacturing
Xencor – VP, Regulatory Affairs & Quality Assurance
Zymeworks – SVP, Research
©2023 BENCH INTERNATIONAL SEARCH, INC. ALL RIGHTS RESERVED.
Website Accessibility | Privacy Notice | Sitemap
